{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:25:13Z","timestamp":1787023513962,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epileptic negative myoclonus (ENM) is a clinically underrecognized seizure type, and systematic data on its clinical manifestations and optimal management strategies in pediatric populations remain scarce. This case series aimed to describe the clinical manifestations, neurophysiological patterns, and therapeutic outcomes in pediatric ENM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective descriptive analysis was conducted on 17 ENM patients diagnosed at Wuxi Children\u2019s Hospital between October 2017 and June 2024. Clinical data, electroencephalogram (EEG) findings, and treatment responses were systematically evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort showed a marked female predominance (female-to-male ratio of 12:5). All cases exhibited upper-limb ENM, with contralateral central-parietal epileptiform discharges observed in ictal EEG. Two patients presented additional lower-limb ENM accompanied by midline discharges. Clinically, ENM manifested as the initial symptom in five cases (29.4%), including two with isolated ENM. Therapeutic outcomes varied: among four non-electrical status epilepticus during sleep (ESES) patients, antiseizure medications (ASMs) achieved symptom control, including one case of oxcarbazepine (OXC)-associated ENM that resolved after transition to valproate (VPA). Of 13 ESES-positive patients, three responded to ASMs alone, while nine received methylprednisolone pulse therapy (MPT), and one surgical candidate with focal cortical dysplasia (FCD) type IIa achieved post-resection remission. Among the nine children treated with MPT: four showed a good response; four relapsed upon steroid withdrawal; and one responded well to ketogenic diet (KD) therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ENM can manifest as the initial or sole epilepsy symptom in children. The marked female predominance in this cohort suggests that sex-related factors may play an important role in the expression or underlying mechanisms of ENM. Additionally, a correlation was found between the EEG discharge patterns and the specific limb regions involved. Regarding treatment, OXC may exacerbate ENM, necessitating cautious use. Steroid therapy should be considered for ESES cases unresponsive to ASMs. Refractory ENM with ESES warrants evaluation for structural abnormalities, particularly cortical dysplasia. Early EEG and neuroimaging improve diagnostic accuracy, while combined therapies-ASMs, immunomodulation, KD, or surgery-optimize outcomes. These findings highlight ENM\u2019s diagnostic intricacy and the need for individualized management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42494-026-00273-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:00Z","timestamp":1787021280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and neurophysiology study of 17 children with epileptic negative myoclonus"],"prefix":"10.1186","volume":"8","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"6","key":"273_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1212\/WNL.43.6.1078","volume":"43","author":"R Guerrini","year":"1993","unstructured":"Guerrini R, Dravet C, Genton P, Bureau M, Roger J, Rubboli G, et al. Epileptic negative myoclonus. Neurology. 1993;43(6):1078\u201383.","journal-title":"Neurology"},{"key":"273_CR2","first-page":"181","volume":"67","author":"CA Tassinari","year":"1995","unstructured":"Tassinari CA, Rubboli G, Parmeggiani L, Valzania F, Plasmati R, Riguzzi P, et al. Epileptic negative myoclonus. Adv Neurol. 1995;67:181\u201397.","journal-title":"Adv Neurol"},{"issue":"6","key":"273_CR3","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/epi.18338","volume":"66","author":"S Beniczky","year":"2025","unstructured":"Beniczky S, Trinka E, Wirrell E, Abdulla F, Al Baradie R, Alonso Vanegas M, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025;66(6):1804\u201323. https:\/\/doi.org\/10.1111\/epi.18338.","journal-title":"Epilepsia"},{"issue":"6","key":"273_CR4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/epi.17241","volume":"63","author":"N Specchio","year":"2022","unstructured":"Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022;63(6):1398\u2013442. https:\/\/doi.org\/10.1111\/epi.17241.","journal-title":"Epilepsia"},{"issue":"12","key":"273_CR5","first-page":"943","volume":"57","author":"P Gong","year":"2019","unstructured":"Gong P, Xue J, Qian P, Yang HP, Zhang YH, Jiang YW, et al. Electroclinical characteristics of epilepsy children with midline epileptiform discharges related epileptic negative myoclonus as the first symptom. Chin J Pediatrics. 2019;57(12):943\u201349.","journal-title":"Chin J Pediatrics"},{"issue":"2","key":"273_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1684\/epd.2011.0433","volume":"13","author":"C Stoyke","year":"2011","unstructured":"Stoyke C, Bilgin O, Noachtar S. Video atlas of lateralising and localising seizure phenomena. Epileptic Disord. 2011;13(2):113\u201324.","journal-title":"Epileptic Disord"},{"issue":"5\u20136","key":"273_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neucli.2006.12.001","volume":"36","author":"G Rubboli","year":"2006","unstructured":"Rubboli G, Tassinari CA. Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management. Neurophysiol Clin. 2006;36(5\u20136):337\u201343. https:\/\/doi.org\/10.1016\/j.neucli.2006.12.001.","journal-title":"Neurophysiol Clin"},{"issue":"Suppl 7","key":"273_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1528-1167.2009.02211.x","volume":"50","author":"M Scheltens-de Boer","year":"2009","unstructured":"Scheltens-de Boer M. Guidelines for EEG in encephalopathy related to ESES\/CSWS in children. Epilepsia. 2009;50(Suppl 7):13\u201317. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02211.x.","journal-title":"Epilepsia"},{"issue":"10","key":"273_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.33588\/rn.6510.2017073","volume":"65","author":"G Azcona","year":"2017","unstructured":"Azcona G, Gurtubay IG, Mosquera A, Ibanez B, Cambra K, Aguilera-Albesa S, et al. A comparative study of three systems for quantifying the spike and wave index in patients with continuous spikes and waves during slow sleep. Rev Neurol. 2017;65(10):439\u201346.","journal-title":"Rev Neurol"},{"issue":"2","key":"273_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/jpn.JPN_137_20","volume":"16","author":"P Arican","year":"2021","unstructured":"Arican P, Gencpinar P, Olgac Dundar N, Tekgul H. Electrical status epilepticus during slow-wave sleep (ESES): current perspectives. J Pediatr Neurosci. 2021;16(2):91\u201396. https:\/\/doi.org\/10.4103\/jpn.JPN_137_20.","journal-title":"J Pediatr Neurosci"},{"key":"273_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.eplepsyres.2014.12.002","volume":"110","author":"M Yoshimura","year":"2015","unstructured":"Yoshimura M, Zhang S, Ueda Y, Matsuda K, Imai K, Takahashi Y, et al. An analysis of epileptic negative myoclonus by magnetoencephalography. Epilepsy Res. 2015;110:139\u201345.","journal-title":"Epilepsy Res"},{"issue":"4","key":"273_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.braindev.2008.04.004","volume":"31","author":"Z Yang","year":"2009","unstructured":"Yang Z, Liu X, Qin J, Zhang Y, Bao X, Chang X, et al. A study on epileptic negative myoclonus in atypical benign partial epilepsy of childhood. Brain Dev. 2009;31(4):274\u201381.","journal-title":"Brain Dev"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2017.09.019","volume":"382","author":"JB Kim","year":"2017","unstructured":"Kim JB, Jung JM, Park MH, Lee EJ, Kwon DY. Negative myoclonus induced by gabapentin and pregabalin: a case series and systematic literature review. J Neurol Sci. 2017;382:36\u201339. https:\/\/doi.org\/10.1016\/j.jns.2017.09.019.","journal-title":"J Neurol Sci"},{"issue":"4","key":"273_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.12701\/yujm.2020.00108","volume":"37","author":"SY Bae","year":"2020","unstructured":"Bae SY, Lee SJ. Negative myoclonus associated with tramadol use. Yeungnam Univ J Med. 2020;37(4):329\u201331. https:\/\/doi.org\/10.12701\/yujm.2020.00108.","journal-title":"Yeungnam Univ J Med"},{"key":"273_CR15","doi-asserted-by":"crossref","unstructured":"Chen J, Zheng G, Guo H, Lu X, Wu C, Wang X, et al. Epileptic negative myoclonus as the first and only symptom in a challenging diagnosis of benign epilepsy with centrotemporal spikes. Child Neurol Open. 2017;4:2329048X17715965.","DOI":"10.1177\/2329048X17715965"},{"issue":"6","key":"273_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pediatrneurol.2010.06.018","volume":"43","author":"A Fujii","year":"2010","unstructured":"Fujii A, Oguni H, Hirano Y, Osawa M. Atypical benign partial epilepsy: recognition can prevent pseudocatastrophe. Pediatr Neurol. 2010;43(6):411\u201319. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2010.06.018.","journal-title":"Pediatr Neurol"},{"issue":"10","key":"273_CR17","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/j.1468-1331.2006.01464.x","volume":"13","author":"S Grosso","year":"2006","unstructured":"Grosso S, Balestri M, Di Bartolo RM, Corbini L, Vatti G, Curatolo P, et al. Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood. Eur J Neurol. 2006;13(10):1142\u201345.","journal-title":"Eur J Neurol"},{"issue":"11","key":"273_CR18","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1111\/j.1528-1167.2007.01210.x","volume":"48","author":"M Vendrame","year":"2007","unstructured":"Vendrame M, Khurana DS, Cruz M, Melvin J, Valencia I, Legido A, et al. Aggravation of seizures and\/or EEG features in children treated with oxcarbazepine monotherapy. Epilepsia. 2007;48(11):2116\u201320. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01210.x.","journal-title":"Epilepsia"},{"key":"273_CR19","doi-asserted-by":"publisher","unstructured":"Yamamoto N, Kuki I, Inoue T, Yamada N, Okazaki S, Shide-Moriguchi Y, et al. Suspected induction of epileptic negative myoclonus after lacosamide initiation. Epilepsia. 2025;66(10):e226\u201331. https:\/\/doi.org\/10.1111\/epi.18595.","DOI":"10.1111\/epi.18595"},{"issue":"7","key":"273_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1515\/revneuro-2020-0020","volume":"31","author":"K Zhang","year":"2020","unstructured":"Zhang K, Yan Y, Su T. Treatment strategies for encephalopathy related to status epilepticus during slow sleep, a narrative review of the literature. Rev Neurosci. 2020;31(7):793\u2013802. https:\/\/doi.org\/10.1515\/revneuro-2020-0020.","journal-title":"Rev Neurosci"},{"issue":"12","key":"273_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/jnnp-2022-329027","volume":"93","author":"A Rangarajan","year":"2022","unstructured":"Rangarajan A, Mundlamuri RC, Kenchaiah R, Prathyusha PV, Viswanathan LG, Asranna A, et al. Efficacy of pulse intravenous methylprednisolone in epileptic encephalopathy: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2022;93(12):1299\u2013305. https:\/\/doi.org\/10.1136\/jnnp-2022-329027.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"273_CR22","doi-asserted-by":"publisher","first-page":"106611","DOI":"10.1016\/j.eplepsyres.2021.106611","volume":"173","author":"A Chatterjee","year":"2021","unstructured":"Chatterjee A, Mundlamuri RC, Kenchaiah R, Asranna A, Nagappa M, Bindu PS, et al. Role of pulse methylprednisolone in epileptic encephalopathy: a retrospective observational analysis. Epilepsy Res. 2021;173:106611.","journal-title":"Epilepsy Res"},{"key":"273_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2019.02.016","volume":"94","author":"A Hempel","year":"2019","unstructured":"Hempel A, Frost M, Agarwal N. Language and behavioral outcomes of treatment with pulse-dose prednisone for electrical status epilepticus in sleep (ESES). Epilepsy Behav. 2019;94:93\u201399. https:\/\/doi.org\/10.1016\/j.yebeh.2019.02.016.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"273_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1474-4422(23)00409-X","volume":"23","author":"MML van Arnhem","year":"2024","unstructured":"van Arnhem MML, van den Munckhof B, Arzimanoglou A, Perucca E, Mets\u00e4honkalaL, Rubboli G, et al. Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial. Lancet Neurol. 2024;23(2):147\u201356.","journal-title":"The Lancet Neurol"},{"key":"273_CR25","doi-asserted-by":"publisher","first-page":"106965","DOI":"10.1016\/j.yebeh.2020.106965","volume":"105","author":"N Wiwattanadittakul","year":"2020","unstructured":"Wiwattanadittakul N, Depositario-Cabacar D, Zelleke TG. Electrical status epilepticus in sleep (ESES) - treatment pattern and EEG outcome in children with very high spike-wave index. Epilepsy Behav. 2020;105:106965.","journal-title":"Epilepsy Behav"},{"key":"273_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.eplepsyres.2016.09.018","volume":"127","author":"SA Kelley","year":"2016","unstructured":"Kelley SA, Kossoff EH. How effective is the ketogenic diet for electrical status epilepticus of sleep? Epilepsy Res. 2016;127:339\u201343. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.09.018.","journal-title":"Epilepsy Res"},{"key":"273_CR27","doi-asserted-by":"publisher","first-page":"110806","DOI":"10.1016\/j.yebeh.2025.110806","volume":"173","author":"MML van Arnhem","year":"2025","unstructured":"van Arnhem MML, van Teeseling HC, van den Berg L, Braun KPJ, Jansen FE. Intelligence outcomes in 17 patients with developmental and\/or epileptic encephalopathy with spike-wave activation in sleep ((D)EE-SWAS) after remission of SWAS. Epilepsy Behav. 2025;173:110806. https:\/\/doi.org\/10.1016\/j.yebeh.2025.110806.","journal-title":"Epilepsy Behav"},{"key":"273_CR28","doi-asserted-by":"publisher","first-page":"106773","DOI":"10.1016\/j.eplepsyres.2021.106773","volume":"177","author":"K Kumar","year":"2021","unstructured":"Kumar K, Yadav N, Banerjee J, Tripathi M, Sharma MC, Lalwani S, et al. Mass spectrometry-based lipidomic analysis reveals altered lipid profile in brain tissues resected from patients with focal cortical dysplasia (FCD). Epilepsy Res. 2021;177:106773.","journal-title":"Epilepsy Res"},{"issue":"4","key":"273_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1684\/epd.2013.0612","volume":"15","author":"RH Caraballo","year":"2013","unstructured":"Caraballo RH, Cers\u00f3simo RO, Fortini PS, Ornella L, Buompadre MC, Vilte C, et al. Congenital hemiparesis, unilateral polymicrogyria and epilepsy with or without status epilepticus during sleep: a study of 66 patients with long-term follow-up. Epileptic Disord. 2013;15(4):417\u201327.","journal-title":"Epileptic Disord"},{"issue":"11","key":"273_CR30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/14737175.2021.1915135","volume":"21","author":"R Guerrini","year":"2021","unstructured":"Guerrini R, Barba C. Focal cortical dysplasia: an update on diagnosis and treatment. Expert Rev Neurother. 2021;21(11):1213\u201324. https:\/\/doi.org\/10.1080\/14737175.2021.1915135.","journal-title":"Expert Rev Neurother"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-026-00273-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-026-00273-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-026-00273-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:02Z","timestamp":1787021282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42494-026-00273-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1186\/s42494-026-00273-3","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"value":"2096-9384","type":"print"},{"value":"2524-4434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Wuxi Children\u2019s Hospital affiliated to Jiangnan University, and parental consent was obtained (Approval number: WXCH2024-05\u2013086).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors acknowledge the use of DeepSeek-V3 (accessed March 2026) to support English language polishing and the reorganization of Discussion section for clarity and flow. The specific prompts used included:\n                      \u201cPlease help me polish this paragraph\u201d\n                      and\n                      \u201cPlease help me restructure the logic of this discussion section.\u201d","order":2,"name":"Ethics","label":"Declaration of AI use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31"}}